The characterization of FLCN as a positive amino acid-induced stimulator of TORC1 activity opens new avenues for research into how the loss of FLCN function results in the tumor formation typical of those affected by Birt–Hogg–Dubé syndrome. This evidence concerns the gene FLCN and neoplasm.